EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling Effects and Pharmacological Mechanisms of Phellodendrine on Inflammatory Bowel Disease

Yufeng Xie, Ziyi Zhou, Xuqianzi Wu, Jiayin Teng, Xiaorun Zhang, Yue Sun, Lixin Chen, Lijian Ding iD, Wei Yuan

Biomolecules · 26.07.2026 · 16 (8) · 1092

DOI: 10.3390/biom16081092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 26.07.2026. Verfasst von Yufeng Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory of Synthetic Pharmaceutical Chemistry, School of Geography and Environmental Engineering, Gannan Normal University,…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Anti-Inflammatory Agents. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ningbo youth science and technology innovation leading project, Natural Science Foundation Project of Jiangxi Province, Educational Commission of Hubei Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the gastrointestinal tract. Current treatments, including anti-inflammatory drugs and biologics, often have limited efficacy and significant side effects, highlighting the need for novel therapeutic approaches. Phellodendrine (PHE) is a characteristic ingredient of Phellodendri chinensis, yet its effects and mechanisms on IBD remain elusive. The present study evaluated the potential of PHE for preventing dextran sulfate sodium-induced IBD in zebrafish. PHE effectively reduced inflammatory cell infiltration and modulated polarized macrophages. The qPCR results further confirmed the down-regulation of pro-inflammatory genes and up-regulation of anti-inflammatory factors. Consequently, PHE promoted the resolution of IBD inflammation. PHE also restored intestinal barrier integrity by enhancing MUC2 expression, increasing goblet cell counts, and reducing intestinal permeability of both chemical and physical barriers. In addition, PHE was associated with alterations in the gut microbiome, including a reduction in potentially pathogenic microbes and an increase in beneficial microbial populations. PHE also alleviated oxidative stress. Network pharmacology suggested the potential involvement of the IL-17 signaling pathway, the lipid and atherosclerosis pathway, and the TNF signaling pathway in the preventive effects of PHE against intestinal inflammation in the zebrafish model. In vivo gene expression analysis suggested that JUN, PTGS2, IL1B, DRD2, CALM1, and HSP90AA1 may serve as putative targets of PHE. Collectively, our results indicate that PHE demonstrates potential anti-inflammatory and barrier-protective activities in a zebrafish model of intestinal inflammation. The pharmacological mechanisms by which PHE restores intestinal barriers (microbial, chemical, physical, and immune barriers) include resolving inflammation, decreasing ROS production, and enhancing lipid accumulation in the lumen overlying the intestinal mucus barrier. This study provides novel insights into the preventive effects of PHE against intestinal inflammation in a zebrafish model, suggesting its potential as a candidate for further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesAnti-Inflammatory AgentsAnimalsZebrafishOxidative StressGastrointestinal MicrobiomeIntestinal Barrier FunctionDextran SulfateDisease Models, AnimalInflammationQuinolizines

Stichwörter der Autor:innen

Phellodendrineanti-inflammationgut microbiotainflammatory bowel diseaseintestinal barrieroxidative stress

Substanzen

phellodendrineAnti-Inflammatory AgentsDextran SulfateQuinolizines

Autor:innen und Institutionen

  • Jiangxi Provincial Key Laboratory of Synthetic Pharmaceutical Chemistry, School of Geography and Environmental Engineering, Gannan Normal University, Ganzhou 341000, China.
  • School of Pharmacy, Health Science Center, Ningbo University, Ningbo 315211, China.

ORCID-Profile: Lijian Ding

Förderung

  • Ningbo youth science and technology innovation leading project
  • Natural Science Foundation Project of Jiangxi Province
  • Educational Commission of Hubei Province of China
  • Research Project of Wuhan Polytechnic University
  • Degree and Graduate Education Reform Research Project of Gannan Normal University
  • Gannan Normal University Training Program of Innovation and Entrepreneurship for Undergraduates
  • Special Fundfor Graduate Student Innovation Gannan Normal University
  • Wuhan Polytechnic University

Zitieren

APA

Xie, Y., Zhou, Z., Wu, X., Teng, J., Zhang, X., Sun, Y., Chen, L., Ding, L., & Yuan, W. (2026). Unraveling Effects and Pharmacological Mechanisms of Phellodendrine on Inflammatory Bowel Disease. Biomolecules, 16(8), 1092. https://doi.org/10.3390/biom16081092

Vancouver

Xie Y, Zhou Z, Wu X, Teng J, Zhang X, Sun Y, et al. Unraveling Effects and Pharmacological Mechanisms of Phellodendrine on Inflammatory Bowel Disease. Biomolecules. 2026;16(8):1092. doi:10.3390/biom16081092

BibTeX
@article{Xie2026,
  author = {Xie, Yufeng and Zhou, Ziyi and Wu, Xuqianzi and Teng, Jiayin and Zhang, Xiaorun and Sun, Yue and Chen, Lixin and Ding, Lijian and Yuan, Wei},
  title = {Unraveling Effects and Pharmacological Mechanisms of Phellodendrine on Inflammatory Bowel Disease},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {8},
  pages = {1092},
  doi = {10.3390/biom16081092}
}
Kostenlos starten →